Sorry I didn't write my question very well
I had found the below article for Managing Recall and Market withdrawals and then had read in the technical manual a reference to FDA blood guidances on infectious disease. Within the article it had Table 3. Suggested Approaches for Follow-up of Blood Components Discovered After Transfusion to Have Been in Nonconformance (Biological Product Deviations).
Outside of Lookback for HIV, HCV, and Chagas, is anyone contacting the physician for recalls/market withdrawals received from your blood supplier of any of the items listed like the Malaria-risk travel and if so what guidelines do you use Managing-Recalls-and-Withdrawals.pdf